Tagged with

Turkey * Dr Fabrizio Guidi has left his role as country chair & general manager Rx of Sanofi Turkey and is currently Sanofi’s general manager of diabetics and cardiovascular for Germany, Switzerland and Austria. From January 2019 Dr Guidi will become Sanofi’s general manager primary care GBU Germany, Switzerland and Austria and country…

France In an exclusive interview, Yves L’Epine, president of G5 Santé and CEO of Guerbet, offers his insider take on the business climate in French healthcare and the potential for France to reclaim its position as a global industry power.   Our members are committed to finding the “healthcare integrated solutions…

USA David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the venture investment activity in life sciences for the past year.    In order to have a successful life sciences R&D program, biotech and pharma companies must develop game-changing therapeutics, companion diagnostics and personalized…

Korea National OncoVenture (NOV) is Korea’s Ministry of Health and Welfare funded oncology drug development program to nurture oncology innovation in the country. To maintain high access and limit costs of oncology therapies, we still need to assist in the development of local Korean biotech companies. — Young-Whan Park, President of National…

France INCa – Institut National du Cancer (The National Cancer Institute)       The National Cancer Institute (INCa) is the state agency of health and scientific expertise in oncology in charge of coordinating actions to fight against cancer. Created by the public health law of August 9, 2004, it is placed…

France DSS Direction de la Sécurité (Department of Social Security)   Key People: Director General Mathilde Lignot-Leloup The Directorate of Social Security (DSS) supervises all social security organizations: general scheme funds, basic scheme funds of independent professions other than agricultural, or special schemes funds. It also participates in the supervision of complementary…

France Commission des Affaires Sociales de l’Assemblée Nationale (Commission of Social Affairs, National Assembly)   Key People: Brigitte Bourguignon, Chairwoman Olivier Véran, General Reporter The Social Affairs Committee of the National Assembly is one of the eight standing committees of the French National Assembly. The areas of competence of the Social Affairs Committee are…

Korea Seung-Kyou Lee, vice-president of Korea Bio gives his assessment on the current landscape for biotech firms in Korea. He also discusses Korea Bio’s programme to create a further 1000 biotech firms in Korea within three years.   We are at a critical juncture. If we fail to catch up with…

France Joël Jaouen, president of France Alzheimer, provides important insights into the role and objectives of the patient association. He explains why France Alzheimer together with other learned societies filed a case with the State Council against the French Minister of Health & Solidarity.   Alzheimer’s scares. Why? Because it is…

Korea Young-Whan Park, president of National OncoVenture, discusses their programme to support oncology drug development in South Korea, with a view to discovering and producing a globally competitive, Korean-made oncology medicine. Dr Park also provides his assessment of Korea’s challenge in commercialising its academic research.   NOV not only supports research…

Opinion Emmanuel Fombu, Global Strategy and Digital Innovation Leader at Johnson & Johnson reflects on health professionals’ fears of AI and their place in the healthcare workforce of the future. Sure, robots might be better at carrying out specific operations or at carrying out monotonous tasks without tiring, but it’s the…

France PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in French pharma’s industry, regulatory affairs, reimbursement and pricing.   Maurice-Pierre Planel — President of CEPS Maurice-Pierre Planel Has been heading the Economic Committee of Health Products (CEPS) since December 2015.   CEPS contributes to the development of pharmaceutical policy, implements…